Greenland Mines says Australia grants patent for Klotho gene therapy in neuromuscular diseases

Greenland Mines Ltd.

Greenland Mines Ltd.

GRML

0.00
  • Greenland Mines said IP Australia granted Australian Patent No. 2023252508 covering Klotho gene therapy for neuromuscular diseases.
  • Claims cover muscle-targeted expression of human Klotho s-KL using viral or non-viral delivery systems.
  • Patent adds to the company’s intellectual property supporting its Klotho-based platform, including KLTO-202 for ALS.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Greenland Mines Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607100800PRIMZONEFULLFEED9760045) on July 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.